Skip to main content
Erschienen in: International Ophthalmology 1/2024

01.12.2024 | Original Paper

Unlocking the secrets of success in probing for congenital nasolacrimal duct obstruction: investigating the factors that matter

verfasst von: Seyhan Kocabas, Murat Oklar, Yücel Ozturk, Ozlen Rodop Ozgur

Erschienen in: International Ophthalmology | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The objective of this study was to analyze the impact of different factors on the success rate of probing for congenital nasolacrimal duct obstruction (CNLDO).

Methods

A retrospective analysis was conducted on 239 eyes of 202 patients who underwent probing for CNLDO between 2014 and 2019. Patients were divided into three age groups (12–24 months, 25–36 months, and over 36 months) and two groups based on the type of membranous obstruction (MO) and incomplete complex obstruction (ICO), with complete complex obstruction (CCO) cases being excluded. The study involved administering general anesthesia (GA) to all participants during the probing procedure. The patients were then monitored at scheduled intervals for up to 6 months after the surgery. Success was defined as an improvement in symptoms and signs, and logistic regression and Fisher's exact test were used for statistical analysis.

Results

The mean age of the patients was 25.48 ± 13.38 months, and the total success rate was 86.61%. The success rate for MO was 92.8%, 95.87%, and 97% in age groups 1, 2, and 3, respectively. The success rate for ICO was 91.17%, 80%, and 23.52% in age groups 1, 2, and 3, respectively. The success rate for MO was significantly higher than ICO in all age groups. The success rate for ICO was significantly lower in age group 3 (p = 0.009).

Conclusion

The study found that probing performed within the first 36 months had high success rates regardless of age and type of obstruction. However, the success rate significantly decreased in patients undergoing probing for ICO at 36 months or later.
Literatur
1.
Zurück zum Zitat Schnall BM (2013) Pediatric nasolacrimal duct obstruction. Curr Opin Ophthalmol 24(5):421–424PubMedCrossRef Schnall BM (2013) Pediatric nasolacrimal duct obstruction. Curr Opin Ophthalmol 24(5):421–424PubMedCrossRef
2.
3.
Zurück zum Zitat Sevel D (1981) Development and congenital abnormalities of the nasolacrimal apparatus. J Pediatric Ophthalmol Strabismus 18:13–19CrossRef Sevel D (1981) Development and congenital abnormalities of the nasolacrimal apparatus. J Pediatric Ophthalmol Strabismus 18:13–19CrossRef
5.
Zurück zum Zitat Isenberg SJ et al (1998) Development of tearing in preterm and term neonates. Arch Ophthalmol 116(6):773–776PubMedCrossRef Isenberg SJ et al (1998) Development of tearing in preterm and term neonates. Arch Ophthalmol 116(6):773–776PubMedCrossRef
6.
Zurück zum Zitat Toker E et al (2002) Tear production during the neonatal period. Am J Ophthalmol 133(6):746–749PubMedCrossRef Toker E et al (2002) Tear production during the neonatal period. Am J Ophthalmol 133(6):746–749PubMedCrossRef
7.
Zurück zum Zitat Sathiamoorthi S, Frank RD, Mohney BG (2019) Incidence and clinical characteristics of congenital nasolacrimal duct obstruction. Br J Ophthalmol 103(4):527–529PubMedCrossRef Sathiamoorthi S, Frank RD, Mohney BG (2019) Incidence and clinical characteristics of congenital nasolacrimal duct obstruction. Br J Ophthalmol 103(4):527–529PubMedCrossRef
8.
Zurück zum Zitat Świerczyńska M et al (2020) Success rates of probing for congenital nasolacrimal duct obstruction at various ages. BMC Ophthalmol 20:1–8CrossRef Świerczyńska M et al (2020) Success rates of probing for congenital nasolacrimal duct obstruction at various ages. BMC Ophthalmol 20:1–8CrossRef
9.
10.
11.
Zurück zum Zitat AlHammad F et al (2018) Unilateral congenital nasolacrimal duct obstruction, is it an amblyogenic factor? Middle East Afr J Ophthalmol 25(3–4):156PubMedPubMedCentral AlHammad F et al (2018) Unilateral congenital nasolacrimal duct obstruction, is it an amblyogenic factor? Middle East Afr J Ophthalmol 25(3–4):156PubMedPubMedCentral
12.
Zurück zum Zitat Matta NS, Singman EL, Silbert DI (2010) Prevalence of amblyopia risk factors in congenital nasolacrimal duct obstruction. J Am Assoc Pediatric Ophthalmol Strabismus 14(5):386–388CrossRef Matta NS, Singman EL, Silbert DI (2010) Prevalence of amblyopia risk factors in congenital nasolacrimal duct obstruction. J Am Assoc Pediatric Ophthalmol Strabismus 14(5):386–388CrossRef
13.
Zurück zum Zitat Pediatric Eye Disease Investigator Group (2012) A randomized trial comparing the cost-effectiveness of 2 approaches for treating unilateral nasolacrimal duct obstruction. Arch Ophthalmol 130(12):1525–1533PubMedCentralCrossRef Pediatric Eye Disease Investigator Group (2012) A randomized trial comparing the cost-effectiveness of 2 approaches for treating unilateral nasolacrimal duct obstruction. Arch Ophthalmol 130(12):1525–1533PubMedCentralCrossRef
14.
Zurück zum Zitat Sathiamoorthi S, Frank RD, Mohney BG (2018) Spontaneous resolution and timing of intervention in congenital nasolacrimal duct obstruction. JAMA Ophthalmol 136(11):1281–1286PubMedPubMedCentralCrossRef Sathiamoorthi S, Frank RD, Mohney BG (2018) Spontaneous resolution and timing of intervention in congenital nasolacrimal duct obstruction. JAMA Ophthalmol 136(11):1281–1286PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Birchansky LD et al (1990) Management of congenital lacrimal sac fistula. Arch Ophthalmol 108(3):388–390PubMedCrossRef Birchansky LD et al (1990) Management of congenital lacrimal sac fistula. Arch Ophthalmol 108(3):388–390PubMedCrossRef
16.
Zurück zum Zitat Petersen RA, Robb RM (1978) The natural course of congenital obstruction of the nasolacrimal duct. J Pediatric Ophthalmol Strabismus 15:246–250CrossRef Petersen RA, Robb RM (1978) The natural course of congenital obstruction of the nasolacrimal duct. J Pediatric Ophthalmol Strabismus 15:246–250CrossRef
17.
Zurück zum Zitat Weiss AH, Baran F, Kelly J (2012) Congenital nasolacrimal duct obstruction: delineation of anatomic abnormalities with 3-dimensional reconstruction. Arch Ophthalmol 130(7):842–848PubMedCrossRef Weiss AH, Baran F, Kelly J (2012) Congenital nasolacrimal duct obstruction: delineation of anatomic abnormalities with 3-dimensional reconstruction. Arch Ophthalmol 130(7):842–848PubMedCrossRef
18.
Zurück zum Zitat Moscato EE, Kelly JP, Weiss A (2010) Developmental anatomy of the nasolacrimal duct: implications for congenital obstruction. Ophthalmology 117(12):2430–2434PubMedCrossRef Moscato EE, Kelly JP, Weiss A (2010) Developmental anatomy of the nasolacrimal duct: implications for congenital obstruction. Ophthalmology 117(12):2430–2434PubMedCrossRef
19.
Zurück zum Zitat Mocan MC et al (2015) Prognostic value of metal–metal contact during nasolacrimal duct probing. Can J Ophthalmol 50(4):314–317PubMedCrossRef Mocan MC et al (2015) Prognostic value of metal–metal contact during nasolacrimal duct probing. Can J Ophthalmol 50(4):314–317PubMedCrossRef
20.
Zurück zum Zitat Petris C, Liu D (2017) Probing for congenital nasolacrimal duct obstruction. Cochrane Database of Syst Rev 7(7):CD011109 Petris C, Liu D (2017) Probing for congenital nasolacrimal duct obstruction. Cochrane Database of Syst Rev 7(7):CD011109
21.
Zurück zum Zitat Nelson LB, Calhoun JH, Menduke H (1985) Medical management of congenital nasolacrimal duct obstruction. Ophthalmology 92(9):1187–1190PubMedCrossRef Nelson LB, Calhoun JH, Menduke H (1985) Medical management of congenital nasolacrimal duct obstruction. Ophthalmology 92(9):1187–1190PubMedCrossRef
22.
Zurück zum Zitat Kakizaki H et al (2008) The rate of symptomatic improvement of congenital nasolacrimal duct obstruction in Japanese infants treated with conservative management during the 1st year of age. Clin Ophthalmol 2(2):291–294PubMedPubMedCentralCrossRef Kakizaki H et al (2008) The rate of symptomatic improvement of congenital nasolacrimal duct obstruction in Japanese infants treated with conservative management during the 1st year of age. Clin Ophthalmol 2(2):291–294PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Paul TO (1985) Medical management of congenital nasolacrimal duct obstruction. J Pediatr Ophthalmol Strabismus 22:68–70PubMedCrossRef Paul TO (1985) Medical management of congenital nasolacrimal duct obstruction. J Pediatr Ophthalmol Strabismus 22:68–70PubMedCrossRef
25.
Zurück zum Zitat Katowitz JA, Welsh MG (1987) Timing of initial probing and irrigation in congenital nasolacrimal duct obstruction. Ophthalmology 94(6):698–705PubMedCrossRef Katowitz JA, Welsh MG (1987) Timing of initial probing and irrigation in congenital nasolacrimal duct obstruction. Ophthalmology 94(6):698–705PubMedCrossRef
26.
Zurück zum Zitat Rajabi MT et al (2014) Success rate of late primary probing in congenital nasolacrimal duct obstruction. J Pediatr Ophthalmol Strabismus 51(6):360–362PubMedCrossRef Rajabi MT et al (2014) Success rate of late primary probing in congenital nasolacrimal duct obstruction. J Pediatr Ophthalmol Strabismus 51(6):360–362PubMedCrossRef
27.
Zurück zum Zitat Cakmak SS et al (2010) Is it necessary to accompany probing with endoscopy in cases of congenital nasolacrimal canal obstruction? Int J Pediatr Otorhinolaryngol 74(9):1013–1015PubMedCrossRef Cakmak SS et al (2010) Is it necessary to accompany probing with endoscopy in cases of congenital nasolacrimal canal obstruction? Int J Pediatr Otorhinolaryngol 74(9):1013–1015PubMedCrossRef
28.
Zurück zum Zitat Mannor GE et al (1999) Factors affecting the success of nasolacrimal duct probing for congenital nasolacrimal duct obstruction. Am J Ophthalmol 127(5):616–617PubMedCrossRef Mannor GE et al (1999) Factors affecting the success of nasolacrimal duct probing for congenital nasolacrimal duct obstruction. Am J Ophthalmol 127(5):616–617PubMedCrossRef
29.
Zurück zum Zitat Kashkouli MB, Kassaee A, Tabatabaee Z (2002) Initial nasolacrimal duct probing in children under age 5: cure rate and factors affecting success. J Am Assoc Pediatric Ophthalmol Strabismus 6(6):360–363CrossRef Kashkouli MB, Kassaee A, Tabatabaee Z (2002) Initial nasolacrimal duct probing in children under age 5: cure rate and factors affecting success. J Am Assoc Pediatric Ophthalmol Strabismus 6(6):360–363CrossRef
30.
Zurück zum Zitat Kashkouli M et al (2003) Late and very late initial probing for congenital nasolacrimal duct obstruction: What is the cause of failure? Br J Ophthalmol 87(9):1151–1153PubMedPubMedCentralCrossRef Kashkouli M et al (2003) Late and very late initial probing for congenital nasolacrimal duct obstruction: What is the cause of failure? Br J Ophthalmol 87(9):1151–1153PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Andalib D, Nabei R (2013) Intraoperative prognostic factors for probing outcome in children with congenital nasolacrimal duct obstruction. Eur J Ophthalmol 23(3):329–332PubMedCrossRef Andalib D, Nabei R (2013) Intraoperative prognostic factors for probing outcome in children with congenital nasolacrimal duct obstruction. Eur J Ophthalmol 23(3):329–332PubMedCrossRef
32.
Zurück zum Zitat Crigler LW (1923) The treatment of congenital dacryocystitis. J Am Med Assoc 81(1):23–24CrossRef Crigler LW (1923) The treatment of congenital dacryocystitis. J Am Med Assoc 81(1):23–24CrossRef
33.
Zurück zum Zitat Napier ML et al (2016) Congenital nasolacrimal duct obstruction: comparison of two different treatment algorithms. J Pediatr Ophthalmol Strabismus 53(5):285–291PubMedCrossRef Napier ML et al (2016) Congenital nasolacrimal duct obstruction: comparison of two different treatment algorithms. J Pediatr Ophthalmol Strabismus 53(5):285–291PubMedCrossRef
34.
Zurück zum Zitat MacEwen CJ, Phillips MG, Young JD (1994) Value of bacterial culturing in the course of congenital nasolacrimal duct (NLD) obstruction. J Pediatric Ophthalmol Strabismus 31:246–250CrossRef MacEwen CJ, Phillips MG, Young JD (1994) Value of bacterial culturing in the course of congenital nasolacrimal duct (NLD) obstruction. J Pediatric Ophthalmol Strabismus 31:246–250CrossRef
35.
Zurück zum Zitat Nucci P et al (1989) Conservative management of congenital nasolacrimal duct obstruction. J Pediatric Ophthalmol Strabismus 26:39–43CrossRef Nucci P et al (1989) Conservative management of congenital nasolacrimal duct obstruction. J Pediatric Ophthalmol Strabismus 26:39–43CrossRef
36.
Zurück zum Zitat Young J, MacEwen C, Ogston S (1996) Congenital nasolacrimal duct obstruction in the second year of life: a multicentre trial of management. Eye 10(4):485–491PubMedCrossRef Young J, MacEwen C, Ogston S (1996) Congenital nasolacrimal duct obstruction in the second year of life: a multicentre trial of management. Eye 10(4):485–491PubMedCrossRef
37.
Zurück zum Zitat Repka MX et al (2007) Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years. Ophthalmology 115(3):577–584PubMed Repka MX et al (2007) Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years. Ophthalmology 115(3):577–584PubMed
40.
41.
Zurück zum Zitat Beato J et al (2017) Factors predictive of success in probing for congenital nasolacrimal duct obstruction. J Pediatr Ophthalmol Strabismus 54(2):123–127PubMedCrossRef Beato J et al (2017) Factors predictive of success in probing for congenital nasolacrimal duct obstruction. J Pediatr Ophthalmol Strabismus 54(2):123–127PubMedCrossRef
42.
Zurück zum Zitat Al-Faky YH et al (2012) Evaluation of treatment modalities and prognostic factors in children with congenital nasolacrimal duct obstruction. J Am Assoc Pediatric Ophthalmol Strabismus 16(1):53–57CrossRef Al-Faky YH et al (2012) Evaluation of treatment modalities and prognostic factors in children with congenital nasolacrimal duct obstruction. J Am Assoc Pediatric Ophthalmol Strabismus 16(1):53–57CrossRef
43.
Zurück zum Zitat Une VL, Kulkarni SS, Nandedkar VS (2019) Effect of probing in congenital nasolacrimal duct obstruction in children older than 2 years. J Pediatr Ophthalmol Strabismus 56(3):141–145PubMedCrossRef Une VL, Kulkarni SS, Nandedkar VS (2019) Effect of probing in congenital nasolacrimal duct obstruction in children older than 2 years. J Pediatr Ophthalmol Strabismus 56(3):141–145PubMedCrossRef
44.
Zurück zum Zitat Medghalchi A et al (2014) Results of nasolacrimal duct probing in children between 9–48 months. Acta Med Iran 52:545–551PubMed Medghalchi A et al (2014) Results of nasolacrimal duct probing in children between 9–48 months. Acta Med Iran 52:545–551PubMed
45.
Zurück zum Zitat Macewen CJ (2006) Congenital nasolacrimal duct obstruction. Compr Ophthalmol Update 7(2):79–87PubMed Macewen CJ (2006) Congenital nasolacrimal duct obstruction. Compr Ophthalmol Update 7(2):79–87PubMed
46.
Zurück zum Zitat Cha DS et al (2010) Clinical outcomes of initial and repeated nasolacrimal duct office-based probing for congenital nasolacrimal duct obstruction. Korean J Ophthalmol 24(5):261–266PubMedPubMedCentralCrossRef Cha DS et al (2010) Clinical outcomes of initial and repeated nasolacrimal duct office-based probing for congenital nasolacrimal duct obstruction. Korean J Ophthalmol 24(5):261–266PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Arici C et al (2023) Comparison of endoscopically assisted primary probing and bicanalicular silicone intubation for congenital nasolacrimal duct obstruction in children aged 4 to 7 years. J Pediatr Ophthalmol Strabismus 60(2):101–107PubMedCrossRef Arici C et al (2023) Comparison of endoscopically assisted primary probing and bicanalicular silicone intubation for congenital nasolacrimal duct obstruction in children aged 4 to 7 years. J Pediatr Ophthalmol Strabismus 60(2):101–107PubMedCrossRef
48.
Zurück zum Zitat Eshraghi B et al (2022) Outcome of monocanalicular intubation for complex congenital nasolacrimal duct obstruction: the role of age. Rom J Ophthalmol 66(1):49PubMedPubMedCentral Eshraghi B et al (2022) Outcome of monocanalicular intubation for complex congenital nasolacrimal duct obstruction: the role of age. Rom J Ophthalmol 66(1):49PubMedPubMedCentral
Metadaten
Titel
Unlocking the secrets of success in probing for congenital nasolacrimal duct obstruction: investigating the factors that matter
verfasst von
Seyhan Kocabas
Murat Oklar
Yücel Ozturk
Ozlen Rodop Ozgur
Publikationsdatum
01.12.2024
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 1/2024
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-024-02988-z

Weitere Artikel der Ausgabe 1/2024

International Ophthalmology 1/2024 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.